The NCIDC Announces Its Members are In-Network for the NC State Employee Health Plan's Clear Pricing Network for 2021

The NCIDC is the largest clinically integrated network of independent dermatologists in the state

CARY, NC, UNITED STATES, October 27, 2020 /EINPresswire.com/ — The North Carolina Independent Dermatology Collaboration, a leading clinically integrated dermatology healthcare provider collaboration in the state, announced that its members are in the NC State Health Plan Network for its 2021 launch in North Carolina. The NCIDC has developed plans that align with the State Health Plan's mission to make healthcare more affordable and focus on patients getting better access to independent dermatologists and all the subspecialties of dermatology and improving the quality of dermatologic care.

The main goal of the Clear Pricing Project is to provide a fair and transparent network for members while preserving and protecting the Plan's financial sustainability.

To help members control their health costs and support Clear Pricing Project (CPP) providers, the State Health Plan adds new copay waivers and reductions for 2021. If a member selects a Clear Pricing Project provider as their Primary Care Provider listed on their ID card, their visits are free. If the member visits a Clear Pricing Project specialist, 80/20 Plan members will pay only $40 for a CPP specialist ($80 for a non-CPP specialist), and 70/30 Plan members will pay $47 for a CPP specialist ($94 for a non-CPP specialist).

Many of North Carolina's independent dermatology physician groups have formed a regional collaborative designed to allow them to provide the benefits of a clinically integrated collaboration, including higher efficiency of care, improved quality, more effective delivery, lower costs, and increased savings.

The organization, dubbed the North Carolina Independent Dermatology Collaborative, brings together many dermatology care providers spanning the Triangle area of North Carolina. The physicians have built an organization for independent physicians by physicians to allow the participating physicians to achieve the advantages of being part of a more extensive, clinically integrated system. Member physician practices will facilitate lowering costs while providing high-quality care with the same hometown doctor patients have come to know and trust — all without sacrificing their independence.

The founding members of the Collaborative, in addition to its large general dermatology care base, offers a broad range of dermatology specialties, from Dermatopathology to Pediatric Dermatology and Dermatologic surgery, including Mohs surgery to Cosmetic Dermatology and much more.

Dubbed the North Carolina Independent Dermatology Collaborative, the entity comprises 24 independent dermatology providers who serve estimated 250,000-plus patients in the area. Formed during increasing healthcare consolidation and value-based care models, the collaborative intended to provide higher efficiencies at lower costs than other dermatology providers can offer and a total dermatologic soluti

Parker Eales
North Carolina Independent Dermatology Collaboration
+1 9193034053
email us here


Source: EIN Presswire

Pharmaceutical Compliance Software Market 2020 – Key Application, Opportunities, Demand, Trends, Share, Forecast 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, October 27, 2020 /EINPresswire.com/ — This report has been prepared based on extensive research and analysis of the latest dominating trends in the market. The global Pharmaceutical Compliance Software market has been studied and focus has been on the volume and value of the product/service as well as the manufacturing methods employed. It contains a brief overview of the competitive scene of the key players along with the market introduction and research objectives for the forecast period from 2020 to 2025. The report also presents the market size by observing the historical data and the prospects of the product/service. The economic indicators and the market research methodology have also been provided further in the global Pharmaceutical Compliance Software market report.

Get a Free Sample Report on Pharmaceutical Compliance Software Industry Outlook@ https://www.wiseguyreports.com/sample-request/5976525-global-pharmaceutical-compliance-software-market-growth-status-and

According to this study, over the next five years the Pharmaceutical Compliance Software market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pharmaceutical Compliance Software business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Compliance Software market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Pharmaceutical Compliance Software, covering the supply chain analysis, impact assessment to the Pharmaceutical Compliance Software market size growth rate in several scenarios, and the measures to be undertaken by Pharmaceutical Compliance Software companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Cloud-Based Pharmaceutical Compliance Software
On-Premise Pharmaceutical Compliance Software

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Product Information Management
Pharmaceutical Electronic Registration

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ideagen
Qordata
ACUTA
Lachman Consultant Services
Sparta Systems
Wolters Kluwer
LogicGate
Intagras
Bwise
LogicManager
Qualsys
QUMAS
Med-Script
MasterControl
Axway

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Table of Content

1 Scope of the Report

2 Executive Summary

3 Global Pharmaceutical Compliance Software by Players

4 Pharmaceutical Compliance Software by Regions

5 Americas

6 APAC

7 Europe

8 Middle East & Africa

9 Market Drivers, Challenges and Trends

10 Global Pharmaceutical Compliance Software Market Forecast

11 Key Players Analysis

12 Research Findings and Conclusion

……Continued

Ask Any Query on Pharmaceutical Compliance Software Market Size, Share, and Volume@ https://www.wiseguyreports.com/enquiry/5976525-global-pharmaceutical-compliance-software-market-growth-status-and

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Hospital Software Global Market 2020 – Key Application, Opportunities, Demand, Status, Trends, Share, Forecast 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, October 27, 2020 /EINPresswire.com/ — This report has been prepared based on extensive research and analysis of the latest dominating trends in the market. The global Hospital Software market has been studied and focus has been on the volume and value of the product/service as well as the manufacturing methods employed. It contains a brief overview of the competitive scene of the key players along with the market introduction and research objectives for the forecast period from 2020 to 2025. The report also presents the market size by observing the historical data and the prospects of the product/service. The economic indicators and the market research methodology have also been provided further in the global Hospital Software market report.

Get a Free Sample Report on Hospital Software Industry Outlook@ https://www.wiseguyreports.com/sample-request/5976346-global-hospital-software-market-growth-status-and-outlook-2020-2025

According to this study, over the next five years the Hospital Software market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Hospital Software business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital Software market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Hospital Software, covering the supply chain analysis, impact assessment to the Hospital Software market size growth rate in several scenarios, and the measures to be undertaken by Hospital Software companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
EHR/EMR
Medical CRM
Websites and Patient Portals
Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Private Hospital
Public Hospital

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
eClinicalWorks
NextGen Healthcare
McKesson
Allscripts
Athena Health
Cerner Corp
Quest Diagnostics (DELL)
GE Healthcare
Optum Health
Epic Systems Corp
Meditech
Computer Programs and Systems
Compugroup Medical
Practice Fusion
Merge Healthcare (IBM)
Carestream Health
Agfa HealthCare
Sunquest Information Systems
Greenway Health
Lexmark Healthcare
Winning Health Technology
Neusoft

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Table of Content

1 Scope of the Report

2 Executive Summary

3 Global Hospital Software by Players

4 Hospital Software by Regions

5 Americas

6 APAC

7 Europe

8 Middle East & Africa

9 Market Drivers, Challenges and Trends

10 Global Hospital Software Market Forecast

11 Key Players Analysis

12 Research Findings and Conclusion

……Continued

Ask Any Query on Hospital Software Market Size, Share, and Volume@ https://www.wiseguyreports.com/enquiry/5976346-global-hospital-software-market-growth-status-and-outlook-2020-2025

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

CORONA STUDY USING DELTAREX-G FOR COVID-19

Graphic illustration of DeltaRex-G vector. The DeltaRex-G vector displaying disease targeting peptide (A), for binding to exposed collagenous (XC) proteins in COVID-19 diseased sites (B), and encoding a gene for killing immune cells causing ARDS

Available now: “Right to Try” DeltaRex-G for COVID-19 EMERGENCY USE

DeltaRex-G is the first, and so far, only, disease-targeted gene therapy that has the potential of effectively treating COVID-19 induced Cytokine Storm and Respiratory Distress Syndrome”.”

— Erlinda M. Gordon, M.D.

LOS ANGELES, CA, UNITED STATES, October 27, 2020 /EINPresswire.com/ — The Aveni Foundation is proud to announce its new mission to treat COVID-19 induced pneumonia/Acute Respiratory Distress Syndrome , as presented by Dr. Erlinda M. Gordon, President of the Aveni Foundation, at the recent COVID-19 Symposium sponsored by the American Society of Gene and Cell Therapy. According to Dr. Gordon, “DeltaRex-G is the first, and so far, only, disease-targeted gene therapy that has the potential of effectively treating COVID-19 induced Cytokine Storm and Respiratory Distress Syndrome”.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This aggressive and highly infectious virus can lead to life threatening complications including cytokine storm (raging fevers, headaches, intense fatigue, muscle aches, loss of taste and smell) and acute respiratory distress syndrome (difficulty breathing from pneumonia leading to respiratory failure). These complications are the main causes of death in this global pandemic. However, these complications are believed to be caused not by the virus itself, but by an exaggerated immune reaction to the infection. The overactive immune cells are thought to make certain proinflammatory chemicals (cytokines) that cause raging fevers and damage to the lungs and other organs.

Over 1000 clinical trials are on-going worldwide to diagnose, treat, and improve the rate of recovery from COVID-19. So far, there are a few promising drugs but no FDA-approved treatment for COVID-19. We announce DeltaRex-G, the first, and so far, only, gene therapy for treatment of COVID-19 induced Cytokine Storm and Respiratory Distress Syndrome.

WHY DELTAREX-G FOR COVID-19?

1) DeltaRex-G has a navigational system that seeks out areas of injury (e.g. inflamed lung), thus increasing the drug concentration in injured sites, where overactive immune cells are creating havoc. Our hypothesis is that DeltaRex-G can hasten recovery from pneumonia/ARDS and prevent chronic lung disease by killing the activated immune cells causing ARDS and the proliferative fibroblasts causing chronic lung disease;

2) DeltaRex-G has been given to over 280 cancer patients with few, if any, toxic side effects; and

3) DeltaRex-G is already FDA approved for the Foundation’s “Right-to-Try” Expanded Access Program as treatment of Stage 4 cancer.

WHAT IS THE STUDY ABOUT?

The CORONA STUDY is a Phase 1/2 study that will test whether DeltaRex-G is safe, will improve the symptoms of COVID-19, will hasten patient recovery from pneumonia/ARDS and will prevent chronic lung disease induced by COVID-19.

The Aveni Foundation (www.avenifoundation.org) is raising $5 Million USD for this upcoming study: The CORONA study Using DeltaRex-G for COVID-19 (www.clinicaltrials.gov: NCT04378244). However, available now is a limited supply of DeltaRex-G for “Right to Try” EMERGENCY USE.

TO DONATE: go to www.avenifoundation.org, click on CONTRIBUTE, or write a check payable to: Aveni Foundation, 2811 Wilshire Blvd., Suite 777, Santa Monica CA 90403; or Wire funds to: Chase Bank, Account Name: Aveni Foundation, Routing No: 322 271 627, Checking Acct. No.: 317 312 673, SWIFT CHASUS33.

For more information, email Dr. Gordon at egordon@avenifoundation.org or egordon@sarcomaoncology.com.

Erlinda Maria Gordon
Aveni Foundation
+1 818-726-3278
email us here

Erlinda M. Gordon, MD- DeltaRex-G Targeted Gene Therapy for COVID-19


Source: EIN Presswire

Transpersonal Psychologist Dr. Sheila Krystal to be Featured on Close Up Radio

BERKLEY, CALIFORNIA, UNITED STATES, October 27, 2020 /EINPresswire.com/ — Right now, the collective human race is concerned with the COVID-19 pandemic. Loved ones are getting sick. People are suffering from financial distress. Some are paralyzed by fear. Others are angry or depressed.

But there are silver linings in this dark cloud. We must refocus our attention in ways that are productive instead of destructive. What we pay attention to most determines our emotions and mood. We can stay optimistic, more positive, more centered, when we work with our brain’s neuroplasticity.

“When we all go to sleep at night, we are awash in the collective unconscious, which since COVID-19, contains fear, anger, impatience and depression,” says transpersonal psychologist Dr. Sheila Krystal. “Many of us wake up afraid. Some are even having panic attacks, and the sympathetic nervous system is on full blast. My hope is to help people know what to do when that happens.”

According to Dr. Krystal, psychological work must include all 4 dimensions: the physical body (improving health, diet, exercise, sleep), the emotional plane and autonomic nervous system regulation, the mental realm and quieting the monkey mind and finally the spiritual dimension promoting more reliance on the inner world and on mindfulness.

“People don’t have to be victims of their conditioning and past and trauma,” says Dr. Krystal. “We now understand that the brain can change itself, and we can participate in that change by focusing our attention on the present moment and what is positive in our lives and count our blessings. If we focus only on gratitude and appreciation for a minimum of thirty seconds, we can participate in our brain’s neuroplasticity and create and reinforce new neural networks for optimism, positivity and compassion.”

Indeed, the virus has given us the opportunity to reexamine our priorities. Dr. Krystal recommends finding a therapist who offers eye movement desensitization and reprocessing (EMDR) and mindfulness training, especially for trauma.

“I work with meditation, centering self-awareness techniques, visualization, CBT and EMDR with clients,” says Dr. Krystal.

Close Up Radio will feature Dr. Sheila Krystal in an interview with Jim Masters on October 29th at 2pm EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

Lou Ceparano
Close Up Television & Radio
+ +1 (631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Historic Billion-Dollar Settlement Renews Hope for Those Struggling With Opioid Use

Waismann Method® Advanced Treatment of Opiate Dependence

Waismann Method® Advanced Treatment of Opiate Dependence

Clare Waismann, Certified Addiction Treatment Counselor, founder of Waismann Method® and Domus Retreat®

Clare Waismann, Certified Addiction Treatment Counselor, founder of Waismann Method® and Domus Retreat®

Michael Lowenstein, M.D., Waismann Method® Medical Director

Michael Lowenstein, M.D., Waismann Method® Medical Director

A historic settlement against OxyContin maker, Purdue Pharma, can provide financial relief plus well-deserved justice for the victims of the opioid crisis.

May [the money] provide those who desire to come off opioids the ability to receive adequate medical care through the withdrawal phase, followed by the necessary professional mental health support.”

— Clare Waismann

BEVERLY HILLS, CALIFORNIA, UNITED STATES, October 27, 2020 /EINPresswire.com/ — On Wednesday, the Justice Department announced that OxyContin-maker Purdue Pharma agreed to plead guilty to three felony criminal charges including violating the anti-kickback laws and conspiracy to defraud the United States. The historic $8.3 billion settlement — the largest such settlement ever reached with a pharmaceutical company — is the result of a years-long criminal investigation. The penalties include a criminal fine of $3.544 billion. Purdue must make a direct payment of $225 million to the government as part of a larger $2 billion criminal forfeiture.

The Sackler family will lose control over their company. Subject to approval by the bankruptcy court of the Southern District of New York, the company would cease to operate in its current form and would be governed by a trust as a public benefit company (PBC). The trust is designed to benefit the American public. The Department of Justice is willing to credit up to $1.775 billion against the $2 billion and channel that to State and local governments.

Jeff Rosen, Deputy Attorney General, said that this settlement “will redress past wrongs, and will also provide extraordinary new resources for treatment and care of those affected by opioid addiction.”

Compensating victims and funding effective treatment centers is the right thing to do, and it makes sense economically. The CDC estimates that the total “economic burden” of opioid misuse in this country is about $78.5 billion each year.

Clare Waismann, the founder of Waismann Method® Advanced Treatment of Opiate Dependence and Domus Retreat, is hopeful these funds will make a difference in victims’ lives.

“May the money be used wisely to educate, prevent, and treat our citizens. May it also provide those who desire to come off opioids the ability to receive adequate medical care in a hospital through the withdrawal phase, followed by the necessary professional mental health support,” Clare said.

This settlement can provide a financial reward, and some well-deserved justice for those individuals who became victims of the opioid crisis.

Individuals continue to seek numbing devices to self-medicate the emotional distress that continuously overwhelms them. Convincing people that they are “addicts” or have an “addictive personality” is unproductive and harmful.

We need to see them, hear them, and, most of all, understand their struggles. Let us replace condemnation with education, mental health care, and medical treatment when needed. Only then, will we really start saving lives.

For more information about Waismann Method®, please visit www.opiates.com. For interviews, contact Clare Waismann at 800-423-2482 or send an email to info@opiates.com.

About Waismann Method® Opioid Treatment Specialists

Clare Waismann is the founder of Waismann Method® and is a Certified Addiction Treatment Counselor. For over 21 years, Waismann Method® has successfully treated thousands of patients struggling with opioid use disorder. Clare has spent over two decades tirelessly fighting to increase access to medically-assisted detox, mental health care and to end the unjust stigma associated with opioid use disorder.

Waismann Method® provides opioid users with the highest level of individualized medical-based detoxification treatment. The center’s medical director, Dr. Michael H. Lowenstein, is a quadruple board-certified M.D. He is highly recognized for his expertise in medically-assisted opioid treatment (including rapid detox), the successful management of pain, and anesthesiology. Trusted since 1998, patients from around the world have come to the facility located exclusively in Southern California for treatment of opioid dependence in a private, full-service accredited hospital.

Clare Waismann
Waismann Method
+1 800-423-2482
info@opiates.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Inhalation Sedatives Market Trend: Production Of Generic Inhalation Sedatives

Inhalation Sedatives Market Report 2020-30: COVID-19 Growth And Change

Inhalation Sedatives Global Market Report 2020-30: COVID-19 Growth And Change

The Business Research Company’s Global Inhalation Sedatives Market Report 2020-30: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, October 27, 2020 /EINPresswire.com/ — The production of generic inhalation sedatives is expected to be an emerging trend in the inhalation sedatives market. Generics are a type of drug that have the same chemical formula, dosage form, dose and effect as that of the patented drug, but are produced by companies when the patent expires. Generic inhalation sedatives production has increased over the last few years. For instance, in January 2019, Novartis’ division Sandoz launched a liquid for inhalation called desflurane in the United States, a first generic of an inhalation agent suprane that is used for induction and maintenance in adults and paediatrics. Health Canada has given a receipt of a drug identification number to Blue-Zone Technologies Ltd that permits it to launch the generic desflurane drug. Therefore, the production of generic inhalation sedatives is expected to become the new trend in the inhalation sedatives market.

The global inhalation sedatives market size is expected to increase from $1.27 billion in 2019 to $1.29 billion in 2020 at a compound annual growth rate (CAGR) of 1.2%. The growth is mainly due to the COVID-19 outbreak. The infected individuals with severe ARDS require sedation most frequently, and inhalation sedatives are being increasingly considered as they are associated with rapid onset of inhalation and effective outcomes. Inhaled sedatives can reduce lung inflammation, shorten the duration of ventilation and potentially improve survival. The global inhalation sedatives market share is then expected to stabilize and reach $1.48 billion in 2023 at a CAGR of 4.8%.

The short onset and duration time of inhalation sedatives is expected to drive the inhalation sedative market. Rapid onset of inhalation sedative and quick recovery rate makes it applicable for short procedures especially in dental surgeries of paediatrics, and in intensive care units, for decreasing the pain and quick recovery. For instance, the most commonly used inhaled sedative is nitrous oxide dosage, which is administered as a mixture of 30-70% of oxygen, takes about 1-2 minutes to act, and the duration of action is 5 minutes. The short time required for the onset of action and its short duration makes nitrous oxide the most used inhalation sedative for dental treatment. Therefore, the short onset and duration time of inhalation sedatives is expected to drive the inhalation sedatives market.

The inhalation sedatives market consists of sales of inhalation sedatives by companies who manufacture them. Inhalation sedatives are the drugs used to induce or maintain inhalation sedation, which is a type of conscious sedation where a drug is inhaled to suppress the central nervous system activity so that there is not much stress on the patient during a surgical process or a treatment, and so that patient responds to the physician’s commands without protective reflexes. Inhalation sedatives are used in hospitals, ambulatory surgical centers and other care providing centers.

Here Is A List Of Similar Reports By The Business Research Company:

Intravenous Infusion Pump Global Market Report 2020-30: COVID 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pump-global-market-report-2020-30-covid-19-growth-and-change)

Implantable Infusion Pumps Global Market Report 2020-30: COVID 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report-2020-30-covid-19-growth-and-change)

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Mask Customization Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020 – 2026

Latest Market Analysis Research Report on “Global Mask Customization Market 2020” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, October 27, 2020 /EINPresswire.com/ — Global Mask Customization Industry

New Study Reports “Mask Customization Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Overview

This market overview report gives a compelling market insight into that Global Mask Customization Market. Those market insights include its products & services, technology utilization, innovations, resource management, etc. It also puts some focus on the demand and supply graph of this Mask Customization Market. It also gives market segment knowledge and recent market trends. The main thing is that this report gives a piece of overall information about customer satisfaction and also analyzed whether the products & services reach up to each end-user or not. This report analyzed a market potentiality from every required prospective and has taken 2020 as the forecast year.

The key players covered in this study
Customink
Etsy
Vistaprint
Zazzle
Canvasdiscount
Signs
Realthread
Spreadshirt
Bagsoflove
Printful
Printerpix

Try Sample of Global Mask Customization Market @    https://www.wiseguyreports.com/sample-request/5974364-global-mask-customization-market-size-status-and-forecast-2020-2026

Market segment by Type, the product can be split into
Cotton
PVC
Non-Woven Polypropylene
Ethylene-vinyl Acetate

Market segment by Application, split into
Medical Protection
Daily Use

Analysis of market dynamics

This report introduced the whole market dynamics in a global context. Its market analysis part has quite effective, and analysts have focused on this Global Mask Customization Market's various market dimensions. This market analysis gives much relevant information about recent market trends, market competition levels, new competitors, market movement, etc. that can help this Mask Customization Market towards growth improvement. This report also tells about competitor's pricing model, their product uniqueness, revenue generation, etc. This report also described expected risks, which can help that Global Mask Customization Market avoid them up to a certain level. Analysts have examined this Mask Customization Market's market movement and stated reasons for its upward or downward movement.

Market segment analysis

Segmental analysis is quite essential to know the market potentiality in a global scenario. Also, this report examined the Global Mask Customization Market's impact on other market segments. This segmental description can help that Mask Customization Market improve its product & service level, strategies, USP, etc. along with future opportunities. This report has prepared by taking multiple marketing aspects into account, such as sales volume, cash flow management, resources management, labor management, budget planning, etc. that can help that Global Mask Customization Market sustains in the long run.

Key players

This report gives all the required information about this Global Mask Customization Market's vendors. It will help this Global Mask Customization Market to improve its quality and performance level. It tells about all market functionality of key players, their strategies, technology adoption, etc. This report will help this Mask Customization Market to reach up to its customers. 

Report covers:

Comprehensive research methodology of Global Mask Customization Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Mask Customization Market.
Insights about market determinants which are stimulating the Global Mask Customization Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/5974364-global-mask-customization-market-size-status-and-forecast-2020-2026

Some points from table of content:

1 Report Overview
2 Global Growth Trends
3 Competition Landscape by Key Players
4 Mask Customization Breakdown Data by Type
5 Mask Customization Breakdown Data by Application
6 North America
7 Europe
8 Asia-Pacific
9 Latin America
10 Middle East & Africa
11Key Players Profiles
11.1 Customink
11.1.1 Customink Company Details
11.1.2 Customink Business Overview
11.1.3 Customink Mask Customization Introduction
11.1.4 Customink Revenue in Mask Customization Business (2015-2020))
11.1.5 Customink Recent Development
11.2 Etsy
11.2.1 Etsy Company Details
11.2.2 Etsy Business Overview
11.2.3 Etsy Mask Customization Introduction
11.2.4 Etsy Revenue in Mask Customization Business (2015-2020)
11.2.5 Etsy Recent Development
11.3 Vistaprint
11.3.1 Vistaprint Company Details
11.3.2 Vistaprint Business Overview
11.3.3 Vistaprint Mask Customization Introduction
11.3.4 Vistaprint Revenue in Mask Customization Business (2015-2020)
11.3.5 Vistaprint Recent Development
11.4 Zazzle
11.4.1 Zazzle Company Details
11.4.2 Zazzle Business Overview
11.4.3 Zazzle Mask Customization Introduction
11.4.4 Zazzle Revenue in Mask Customization Business (2015-2020)
11.4.5 Zazzle Recent Development
11.5 Canvasdiscount
11.5.1 Canvasdiscount Company Details
11.5.2 Canvasdiscount Business Overview
11.5.3 Canvasdiscount Mask Customization Introduction
11.5.4 Canvasdiscount Revenue in Mask Customization Business (2015-2020)
11.5.5 Canvasdiscount Recent Development
11.6 Signs
11.6.1 Signs Company Details
11.6.2 Signs Business Overview
11.6.3 Signs Mask Customization Introduction
11.6.4 Signs Revenue in Mask Customization Business (2015-2020)
11.6.5 Signs Recent Development
11.7 Realthread
11.7.1 Realthread Company Details
11.7.2 Realthread Business Overview
11.7.3 Realthread Mask Customization Introduction
11.7.4 Realthread Revenue in Mask Customization Business (2015-2020)
11.7.5 Realthread Recent Development
11.8 Spreadshirt
11.8.1 Spreadshirt Company Details
11.8.2 Spreadshirt Business Overview
11.8.3 Spreadshirt Mask Customization Introduction
11.8.4 Spreadshirt Revenue in Mask Customization Business (2015-2020)
11.8.5 Spreadshirt Recent Development
11.9 Bagsoflove
11.9.1 Bagsoflove Company Details
11.9.2 Bagsoflove Business Overview
11.9.3 Bagsoflove Mask Customization Introduction
11.9.4 Bagsoflove Revenue in Mask Customization Business (2015-2020)
11.9.5 Bagsoflove Recent Development
11.10 Printful
11.11 Printerpix
11.12 Yourprint
12Analyst's Viewpoints/Conclusions
13Appendix

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire

The Global Cancer Clinical Decision Tools Market Share Will Grow At 10.23% CAGR To 2023

Cancer Clinical Decision Tools Market Report 2020-30: COVID-19 Growth And Change

Cancer Clinical Decision Tools Global Market Report 2020-30: COVID-19 Growth And Change

The Business Research Company’s Global Cancer Clinical Decision Tools Market Report 2020-30: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, October 27, 2020 /EINPresswire.com/ — The global cancer clinical decision support market size is expected to decline from $0.38 billion in 2019 to $0.35 billion in 2020 at a compound annual growth rate (CAGR) of -7.41%. The decline is mainly due to the COVID-19 outbreak that has deferred treatment for cancer unless the conditions are serious. The global cancer clinical decision tools market share is then expected to recover and reach $0.47 billion in 2023 at a CAGR of 10.23%.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision tools market. According to the National Cancer Institute, the rate of incidence based on cases between 2013–2017 cases is 442.4 per 100,000 men and women per year. According to the American Cancer Society, there were 1.7 million new cases and 0.6 cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the market growth.

The cancer clinical decision tools market consists of sales of cancer decision support tools and related services. Cancer decision tools are designed to support the general practitioner’s assessment of patients with potential cancer symptoms. The tools do not change the clinical judgment but give more information that is used to inform patient management decisions. The risk is measured based on reading coded information from the patient record including demographic data, medical history, and symptoms.

The global cancer clinical decision tools market is segmented by type into Risk Assessment Tool (RAT) and Qcancer. By End-User, the market is segmented into hospital and clinics.

The breach of data and privacy of patients is a major challenge in the cancer clinical decision tools market. Hackers can get access to data centers through healthcare employee’s emails leading to a breach of patients’ information privacy. For instance, in 2019, the Regional Cancer Care Association (RCCA) reported a data breach through phishing email attempts. Email phishing is a primary attack because it is not detectable by email security tools. Similarly, in 2018, out of 15 million patient records breached, 11.4 million records were caused by phishing attacks. The risk of the loss of data and privacy of patients harms the growth of the cancer clinical decision tools market.

The major players covered in the global cancer clinical decision tools market are McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers, Elsevier B.V., Macmillan, and National Decision Support Company.

Here Is A List Of Similar Reports By The Business Research Company:

Cancer Diagnostics Global Market Report 2020-30: Covid 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report)

Cancer Biologics Global Market Report 2020-30: Covid 19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report)

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Delaware US Navy Veterans Lung Cancer Advocate Appeals to the Family of a Navy Veteran in Delaware with Lung Cancer Who Also Had Asbestos Exposure to Asbestos to Call the Lawyers at Karst von Oiste About Compensation

"Most Navy Veterans who had heavy exposure to asbestos decades ago and develop lung cancer never get compensated-even though most should-as the lawyers at Karst von Oiste at 800-714-0303 will explain.”

— Delaware US Navy Veterans Lung Cancer Advocate

WILMINGTON , DELAWARE , USA, October 27, 2020 /EINPresswire.com/ — The Delaware US Navy Veterans Lung Cancer Advocate says, "We are appealing to the member of the American Legion or VFW who has a Navy Veteran friend with lung cancer in Delaware to ask him if he had heavy exposure to asbestos in the navy in the 1960s, or 1970s? If the answer is yes-he did–please ask his wife or family to call the lawyers at the law firm of Karst von Oiste anytime at 800-714-0303. Financial compensation for a person like this might exceed $100,000 and it does not involve suing the navy. The average Navy Veteran we are trying to identify is well over 60 years old and it does not matter if he smoked cigarettes. Most people like this do not realize that the $30 billion dollar-asbestos trust funds were set up for them too." www.karstvonoiste.com/

The lawyers at the law firm of Karst von Oiste have been assisting Navy Veterans and people with asbestos exposure lung cancer and mesothelioma for decades and they are responsible for over a billion dollars for people like this. "Most Navy Veterans who had heavy exposure to asbestos decades ago and develop lung cancer never get compensated-even if they should. For direct access to the lawyers at Karst von Oiste please call 800-714-0303 anytime." www.karstvonoiste.com/

The Delaware US Navy Veterans Lung Cancer Advocate’s free services are available to people with asbestos exposure lung cancer or mesothelioma in Wilmington, Dover, Newark, Middletown, Smyrna, Milford, Seaford or anywhere in Connecticut. https://Delaware.USNavyLungCancer.Com

High risk occupations for asbestos exposure in Delaware include the US Navy, chemical plant workers, Dover Air Force Base, power plant workers, public utility workers, plumbers, electricians, construction workers, welders, machinists, power plant workers, public utility workers, and auto mechanics. https://USNavyLungCancer.Com

According to the American Cancer Society for nonsmokers who have been exposed to asbestos in their workplace the risk of lung cancer is five times that of unexposed workers. https://www.cdc.gov/cancer/lung/statistics/index.htm.

The US Navy Veterans Lung Cancer Advocate says, “If your husband, dad, coworker or neighbor has just been diagnosed with lung cancer and you know they had significant exposure to asbestos in the navy, at a shipyard or while working at a factory, at power plant, public utility, or as a plumber, electrician welder, mechanic or any kind of skilled trades group in any state please have them call us anytime at 800-714-0303. Most people like this never get compensated-even though the asbestos trust funds were set up for them too. We are trying to change this sad fact.” https://USNavyLungCancer.Com

States with the highest incidence of lung cancer include Kentucky, West Virginia, Maine, Tennessee, Mississippi, Ohio, Indiana, Louisiana, Arkansas, Missouri, North Carolina, Rhode Island, Alabama, and Delaware. www.karstvonoiste.com/

For more information about asbestos exposure please visit the NIH’s website on this topic: https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-sheet.

Michael Thomas
Delaware US Navy Veterans Lung Cancer Advocate
+1 800-714-0303
email us here


Source: EIN Presswire